Seres Therapeutics, Inc.
MCRBNASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $19.10M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $2.31$29.98
- Volume (live)
- -
- Avg. volume (3M)
- 71.79K
Seres Therapeutics (MCRB) Stock Price & Financial Analysis
Seres Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.98 - $2.19 |
|---|---|
| 52-Week High | $29.98 |
| 52-Week Low | $2.31 |
| Open | $2.11 |
| Volume (last close) | 53.06K |
| Average Volume (3M) | 71.79K |
| Revenue (TTM) | 2.23M |
|---|---|
| Net Income (TTM) | -22.46M |
| Free Cash Flow (TTM) | -51.28M |
| EPS (TTM) | −$2.44 |
| Profit Margin | -1005.51% |
| Operating Margin | -3761.59% |
| Return on Equity (ROE) | -65.05% |
| Debt to Equity | 1.64 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 19.10M |
|---|---|
| Shares Outstanding | 9.64M |
| Price to Sales (P/S) | 8.55 |
| Price to Book (P/B) | 0.55 |
| EV/EBITDA | 3.17 |
| 50-Day MA | $4.03 |
|---|---|
| 200-Day MA | $7.65 |
| 1-Year Change | −87.99% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Seres Therapeutics at a Glance
As of the Oct 26, 2026 close, Seres Therapeutics (MCRB) has a market capitalization of $19.10M. The stock trades at 8.6× sales. Over the trailing twelve months it lost $22.46M on revenue of $2.23M and burned $51.28M of free cash flow.
As of its latest reported balance sheet, it holds $15.59M in cash and securities against $56.64M of debt, a net debt position of $41.05M.
Seres Therapeutics does not currently pay a dividend.
The share price is down 88.0% over the past year. At $1.98 (the Oct 26, 2026 close) it sits near the bottom of its 52-week range of $2.31 to $29.98, below its 200-day moving average of $7.65.
Frequently Asked Questions About Seres Therapeutics
What is the current stock price for MCRB?
As of the Oct 26, 2026 close, MCRB stock trades at $1.98. The 52-week range is $2.31–$29.98, with a day range of $1.98–$2.19.
What is the P/E ratio for MCRB?
The P/E ratio (Price-to-Earnings) for MCRB is shown in the Key Statistics section. This valuation metric helps compare Seres Therapeutics, Inc. to industry peers.
Does MCRB pay dividends?
Seres Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for MCRB?
Analyst ratings and recommendations for MCRB are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of MCRB?
As of the Oct 26, 2026 close, Seres Therapeutics's market capitalization is $19.1M, classifying it as a micro-cap company. Seres Therapeutics operates in the Healthcare sector within the Biotechnology industry.